The U.S. Food and Drug Administration has expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been…
Source link
Would you like to get the test?
The U.S. Food and Drug Administration has expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been…
Source link
Would you like to get the test?